Therefore, irAEs can be therapeutically detrimental with an increasing trend of combo therapies, considering that the related toxicity needs to be controlled without impairing the ideal anti-tumor effect of ICIs.
← all excerpts
Immunotherapy for Glioblastoma: Current State, Challenges, and Future Perspectives.
1
—
—